SAN ANTONIO, July 11, 2025 (GLOBE NEWSWIRE) — With summer in full swing and families balancing busy schedules, road trips, and rising food costs, Whataburger is stepping in to help make mealtime more convenient and budget-friendly. Recently, Stephanie Hill, Summer Savings Ambassador at Whataburger, participated in a nationwide media tour to share tips for enjoying […]
Whataburger's Stephanie Hill Highlights Delicious and Affordable Summer Meals with YourUpdateTV From Flavor-Packed Bundles to Cool Summer Drinks, Whataburger is Helping Make Mealtime Easier – and More Affordable GlobeNewswire July 11, 2025 SAN ANTONIO, July 11, 2025 (GLOBE NEWSWIRE) — With summer in full swing and families balancing busy schedules, road trips, and rising food
(NYSE:OGN), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Organon To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Organon between November 3, 2022 and April 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon GlobeNewswire July 11, 2025 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Organon To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Organon between November 3, 2022
Immix Biopharma Announces Class-Leading Safety Profile, Allowing Potential Future Indication Expansion GlobeNewswire July 11, 2025 – Absence of neurotoxicity of any grade in low-volume disease to-date – – On track for first Biologics License Application (BLA) approved cell therapy in orphan indication relapsed/refractory AL Amyloidosis – – Potential future indication expansion planned – LOS ANGELES,
(NASDAQ:MIST), MONTREAL and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) — Milestone(R) Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of (i) 31,500,000 of its common shares (the “Shares”), accompanying Series A
(NYSE:XIFR), SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of XPLR Infrastructure, LP f/k/a NextEra Energy Partners, LP (NYSE: XIFR) securities between September 27, 2023 and January 27, 2025, both dates inclusive (the “Class Period”), have until September 8, 2025
Milestone Pharmaceuticals Announces Pricing of $52.5 Million Public Offering of Common Shares, Pre-Funded Warrants, Series A Common Warrants and Series B Common Warrants GlobeNewswire July 11, 2025 MONTREAL and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) — Milestone(R) Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular
XPLR INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that XPLR Infrastructure, LP f/k/a NextEra Energy Partners, LP Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – XIFR GlobeNewswire July 11, 2025 SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP announces
Node.js has become a leading choice for building scalable, high-performance, and real-time applications across industries. Its asynchronous, event-driven architecture allows developers to build lightweight yet powerful backend solutions, ideal for both startups and enterprise-level systems. https://mma.prnewswire.com/media/2429933/Hyperlink_InfoSystem_Logo.jpg Recognizing this demand, Hyperlink InfoSystem, a top global IT services provider, now offers businesses of all sizes the opportunity